2Elias DM, Ouellet JF. Intraperitoneal chemohypertherrnia: rationale, technique, indications, and results[J]. Surg Oneol Clin N Am, 2001, 10(4) : 915-933.
3Kim JY, Bae HS. A controlled clinical study of serosa-invasive gastric earcinma patients who underwent surgery plus intraperitoneal hyperthermo-cherno-perfusion(IHCP) [J]. Gastric Cancer, 2001, 4(1): 27-33.
4Jansen M, Fass J, Langejurgen E, et al. Effects of intraperitoneal mitomycin C absorbed on activated carbon on adhesion formation and mesothelial cells in vitro[J]. Eur J Surg, 2000, 166(7) : 572-576.
5Yco CH, Noh SH, Shin DW, et al. Recurrences following curative resection for gastric carcinoma [J ]. Br J Surg, 2000, 87 ( 2 ) : 236-242.
6Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure[J]. J Natl Cancer Inst, 1997, 89(7): 480-487.
7Noh SH, Yco CH, Chung HC, et al. Early postoperative intraperitoneal chemotherapy with rnitomycinC, 5-fluorouracil and cisplatin for advanced gastric cancer[J ]. Oneology, 2001, 60 ( 1 ) : 24-30.
8Jansen M, Buchin P, Dreuw B, et al. Prognostic factors for development of peritoneal carcinosis in stomach carcinoma [ J ]. Chirurg, 2001, 72(5): 561-565.
10Kitani K, Morimoto T, Shibata N, et al. Effects of intraperitoneal injection of low-dose CDDP on 3 patients with ascites owing to peritonitis carcinomatosa of gastric and colorectal carcinoma[J]. Gan To Kagaku Ryoho, 2001, 28(11): 1666-1668.
